SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-17-000902
Filing Date
2017-02-23
Accepted
2017-02-23 16:57:12
Documents
100
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clvs-20161231x10k.htm 10-K 3644212
2 EX-10.37 clvs-20161231ex10371e421.htm EX-10.37 22779
3 EX-10.38 clvs-20161231ex10381ee90.htm EX-10.38 327713
4 EX-23.1 clvs-20161231ex2313e97e6.htm EX-23.1 5646
5 EX-31.1 clvs-20161231ex3113b5d9b.htm EX-31.1 20090
6 EX-31.2 clvs-20161231ex312392668.htm EX-31.2 20324
7 EX-32.1 clvs-20161231ex321248996.htm EX-32.1 8050
8 EX-32.2 clvs-20161231ex32273b8b1.htm EX-32.2 8431
9 GRAPHIC clvs20161231x10k001.jpg GRAPHIC 96610
10 GRAPHIC clvs20161231x10k002.jpg GRAPHIC 124290
  Complete submission text file 0001558370-17-000902.txt   13115055

Data Files

Seq Description Document Type Size
11 EX-101.INS clvs-20161231.xml EX-101.INS 2900529
12 EX-101.SCH clvs-20161231.xsd EX-101.SCH 64181
13 EX-101.CAL clvs-20161231_cal.xml EX-101.CAL 85654
14 EX-101.DEF clvs-20161231_def.xml EX-101.DEF 207449
15 EX-101.LAB clvs-20161231_lab.xml EX-101.LAB 625703
16 EX-101.PRE clvs-20161231_pre.xml EX-101.PRE 482900
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 17633317
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences